[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Cancer Gene Therapy-United States Market Status and Trend Report 2013-2023

February 2018 | 139 pages | ID: CE27C5F9E50EN
MIReports Co., Limited

US$ 3,480.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Report Summary

Cancer Gene Therapy-United States Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Cancer Gene Therapy industry, standing on the readers’ perspective, delivering detailed market data and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:

Whole United States and Regional Market Size of Cancer Gene Therapy 2013-2017, and development forecast 2018-2023
Main market players of Cancer Gene Therapy in United States, with company and product introduction, position in the Cancer Gene Therapy market
Market status and development trend of Cancer Gene Therapy by types and applications
Cost and profit status of Cancer Gene Therapy, and marketing status
Market growth drivers and challenges

The report segments the United States Cancer Gene Therapy market as:

United States Cancer Gene Therapy Market: Regional Segment Analysis (Regional Consumption Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):

New England
The Middle Atlantic
The Midwest
The West
The South
Southwest

United States Cancer Gene Therapy Market: Product Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):

Gene Induced Immunotherapy
Oncolytic Virotherapy
Gene Transfer

United States Cancer Gene Therapy Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)

Hospitals
Diagnostics Centers
Research Institutes

United States Cancer Gene Therapy Market: Players Segment Analysis (Company and Product introduction, Cancer Gene Therapy Sales Volume, Revenue, Price and Gross Margin):

Adaptimmune
GlaxoSmithKline
Bluebird bio
Merck
Celgene
Shanghai Sunway Biotech
BioCancell
Shenzhen SiBiono GeneTech
SynerGene Therapeutics
OncoGenex Pharmaceuticals
Genelux Corporation
Cell Genesys
Advantagene
GenVec
BioCancell
Celgene
Epeius Biotechnologies
Introgen Therapeutics
Ziopharm Oncology
Shenzhen SiBiono GeneTech
Altor Bioscience

In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.

CHAPTER 1 OVERVIEW OF CANCER GENE THERAPY

1.1 Definition of Cancer Gene Therapy in This Report
1.2 Commercial Types of Cancer Gene Therapy
  1.2.1 Gene Induced Immunotherapy
  1.2.2 Oncolytic Virotherapy
  1.2.3 Gene Transfer
1.3 Downstream Application of Cancer Gene Therapy
  1.3.1 Hospitals
  1.3.2 Diagnostics Centers
  1.3.3 Research Institutes
1.4 Development History of Cancer Gene Therapy
1.5 Market Status and Trend of Cancer Gene Therapy 2013-2023
  1.5.1 United States Cancer Gene Therapy Market Status and Trend 2013-2023
  1.5.2 Regional Cancer Gene Therapy Market Status and Trend 2013-2023

CHAPTER 2 UNITED STATES MARKET STATUS AND FORECAST BY REGIONS

2.1 Market Status of Cancer Gene Therapy in United States 2013-2017
2.2 Consumption Market of Cancer Gene Therapy in United States by Regions
  2.2.1 Consumption Volume of Cancer Gene Therapy in United States by Regions
  2.2.2 Revenue of Cancer Gene Therapy in United States by Regions
2.3 Market Analysis of Cancer Gene Therapy in United States by Regions
  2.3.1 Market Analysis of Cancer Gene Therapy in New England 2013-2017
  2.3.2 Market Analysis of Cancer Gene Therapy in The Middle Atlantic 2013-2017
  2.3.3 Market Analysis of Cancer Gene Therapy in The Midwest 2013-2017
  2.3.4 Market Analysis of Cancer Gene Therapy in The West 2013-2017
  2.3.5 Market Analysis of Cancer Gene Therapy in The South 2013-2017
  2.3.6 Market Analysis of Cancer Gene Therapy in Southwest 2013-2017
2.4 Market Development Forecast of Cancer Gene Therapy in United States 2018-2023
  2.4.1 Market Development Forecast of Cancer Gene Therapy in United States 2018-2023
  2.4.2 Market Development Forecast of Cancer Gene Therapy by Regions 2018-2023

CHAPTER 3 UNITED STATES MARKET STATUS AND FORECAST BY TYPES

3.1 Whole United States Market Status by Types
  3.1.1 Consumption Volume of Cancer Gene Therapy in United States by Types
  3.1.2 Revenue of Cancer Gene Therapy in United States by Types
3.2 United States Market Status by Types in Major Countries
  3.2.1 Market Status by Types in New England
  3.2.2 Market Status by Types in The Middle Atlantic
  3.2.3 Market Status by Types in The Midwest
  3.2.4 Market Status by Types in The West
  3.2.5 Market Status by Types in The South
  3.2.6 Market Status by Types in Southwest
3.3 Market Forecast of Cancer Gene Therapy in United States by Types

CHAPTER 4 UNITED STATES MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY

4.1 Demand Volume of Cancer Gene Therapy in United States by Downstream Industry
4.2 Demand Volume of Cancer Gene Therapy by Downstream Industry in Major Countries
  4.2.1 Demand Volume of Cancer Gene Therapy by Downstream Industry in New England
  4.2.2 Demand Volume of Cancer Gene Therapy by Downstream Industry in The Middle Atlantic
  4.2.3 Demand Volume of Cancer Gene Therapy by Downstream Industry in The Midwest
  4.2.4 Demand Volume of Cancer Gene Therapy by Downstream Industry in The West
  4.2.5 Demand Volume of Cancer Gene Therapy by Downstream Industry in The South
  4.2.6 Demand Volume of Cancer Gene Therapy by Downstream Industry in Southwest
4.3 Market Forecast of Cancer Gene Therapy in United States by Downstream Industry

CHAPTER 5 MARKET DRIVING FACTOR ANALYSIS OF CANCER GENE THERAPY

5.1 United States Economy Situation and Trend Overview
5.2 Cancer Gene Therapy Downstream Industry Situation and Trend Overview

CHAPTER 6 CANCER GENE THERAPY MARKET COMPETITION STATUS BY MAJOR PLAYERS IN UNITED STATES

6.1 Sales Volume of Cancer Gene Therapy in United States by Major Players
6.2 Revenue of Cancer Gene Therapy in United States by Major Players
6.3 Basic Information of Cancer Gene Therapy by Major Players
  6.3.1 Headquarters Location and Established Time of Cancer Gene Therapy Major Players
  6.3.2 Employees and Revenue Level of Cancer Gene Therapy Major Players
6.4 Market Competition News and Trend
  6.4.1 Merger, Consolidation or Acquisition News
  6.4.2 Investment or Disinvestment News
  6.4.3 New Product Development and Launch

CHAPTER 7 CANCER GENE THERAPY MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA

7.1 Adaptimmune
  7.1.1 Company profile
  7.1.2 Representative Cancer Gene Therapy Product
  7.1.3 Cancer Gene Therapy Sales, Revenue, Price and Gross Margin of Adaptimmune
7.2 GlaxoSmithKline
  7.2.1 Company profile
  7.2.2 Representative Cancer Gene Therapy Product
  7.2.3 Cancer Gene Therapy Sales, Revenue, Price and Gross Margin of GlaxoSmithKline
7.3 Bluebird bio
  7.3.1 Company profile
  7.3.2 Representative Cancer Gene Therapy Product
  7.3.3 Cancer Gene Therapy Sales, Revenue, Price and Gross Margin of Bluebird bio
7.4 Merck
  7.4.1 Company profile
  7.4.2 Representative Cancer Gene Therapy Product
  7.4.3 Cancer Gene Therapy Sales, Revenue, Price and Gross Margin of Merck
7.5 Celgene
  7.5.1 Company profile
  7.5.2 Representative Cancer Gene Therapy Product
  7.5.3 Cancer Gene Therapy Sales, Revenue, Price and Gross Margin of Celgene
7.6 Shanghai Sunway Biotech
  7.6.1 Company profile
  7.6.2 Representative Cancer Gene Therapy Product
  7.6.3 Cancer Gene Therapy Sales, Revenue, Price and Gross Margin of Shanghai Sunway Biotech
7.7 BioCancell
  7.7.1 Company profile
  7.7.2 Representative Cancer Gene Therapy Product
  7.7.3 Cancer Gene Therapy Sales, Revenue, Price and Gross Margin of BioCancell
7.8 Shenzhen SiBiono GeneTech
  7.8.1 Company profile
  7.8.2 Representative Cancer Gene Therapy Product
  7.8.3 Cancer Gene Therapy Sales, Revenue, Price and Gross Margin of Shenzhen SiBiono GeneTech
7.9 SynerGene Therapeutics
  7.9.1 Company profile
  7.9.2 Representative Cancer Gene Therapy Product
  7.9.3 Cancer Gene Therapy Sales, Revenue, Price and Gross Margin of SynerGene Therapeutics
7.10 OncoGenex Pharmaceuticals
  7.10.1 Company profile
  7.10.2 Representative Cancer Gene Therapy Product
  7.10.3 Cancer Gene Therapy Sales, Revenue, Price and Gross Margin of OncoGenex Pharmaceuticals
7.11 Genelux Corporation
  7.11.1 Company profile
  7.11.2 Representative Cancer Gene Therapy Product
  7.11.3 Cancer Gene Therapy Sales, Revenue, Price and Gross Margin of Genelux Corporation
7.12 Cell Genesys
  7.12.1 Company profile
  7.12.2 Representative Cancer Gene Therapy Product
  7.12.3 Cancer Gene Therapy Sales, Revenue, Price and Gross Margin of Cell Genesys
7.13 Advantagene
  7.13.1 Company profile
  7.13.2 Representative Cancer Gene Therapy Product
  7.13.3 Cancer Gene Therapy Sales, Revenue, Price and Gross Margin of Advantagene
7.14 GenVec
  7.14.1 Company profile
  7.14.2 Representative Cancer Gene Therapy Product
  7.14.3 Cancer Gene Therapy Sales, Revenue, Price and Gross Margin of GenVec
7.15 BioCancell
  7.15.1 Company profile
  7.15.2 Representative Cancer Gene Therapy Product
  7.15.3 Cancer Gene Therapy Sales, Revenue, Price and Gross Margin of BioCancell
7.16 Celgene
7.17 Epeius Biotechnologies
7.18 Introgen Therapeutics
7.19 Ziopharm Oncology
7.20 Shenzhen SiBiono GeneTech
7.21 Altor Bioscience

CHAPTER 8 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF CANCER GENE THERAPY

8.1 Industry Chain of Cancer Gene Therapy
8.2 Upstream Market and Representative Companies Analysis
8.3 Downstream Market and Representative Companies Analysis

CHAPTER 9 COST AND GROSS MARGIN ANALYSIS OF CANCER GENE THERAPY

9.1 Cost Structure Analysis of Cancer Gene Therapy
9.2 Raw Materials Cost Analysis of Cancer Gene Therapy
9.3 Labor Cost Analysis of Cancer Gene Therapy
9.4 Manufacturing Expenses Analysis of Cancer Gene Therapy

CHAPTER 10 MARKETING STATUS ANALYSIS OF CANCER GENE THERAPY

10.1 Marketing Channel
  10.1.1 Direct Marketing
  10.1.2 Indirect Marketing
  10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
  10.2.1 Pricing Strategy
  10.2.2 Brand Strategy
  10.2.3 Target Client
10.3 Distributors/Traders List

CHAPTER 11 REPORT CONCLUSION

CHAPTER 12 RESEARCH METHODOLOGY AND REFERENCE

12.1 Methodology/Research Approach
  12.1.1 Research Programs/Design
  12.1.2 Market Size Estimation
  12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
  12.2.1 Secondary Sources
  12.2.2 Primary Sources
12.3 Reference


More Publications